NORDSON CORP (NDSN)
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NDSN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NDSN | Chairman, CEO and President, Samothrace Medical Innovations, Inc. | 64 | ["Globus Medical Inc.", "Maravai LifeSciences Holdings, Inc.", "Chairman, CEO and President of Samothrace Medical Innovations, Inc.", "Former executive vice president and chief technology officer of Becton, Dickinson and Company", "Senior vice president of Science, Technology and Clinical Affairs for C.R. Bard, Inc.", "Managing director of Early Stage Partners", "President and chief executive officer of Cook Incorporated", "Holds 14 U.S. patents", "Author of numerous peer-reviewed scientific papers", "Ph.D in Electrical Engineering", "Experience in mergers and acquisitions and corporate governance"] | ["Compensation", "Governance and Sustainability"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. DeFord is currently chairman, chief executive officer and president of Samothrace Medical Innovations, Inc., a privately held medical technology company, which he co-founded in March 2022. Previously, Dr. DeFord served as executive vice president and chief technology officer of Becton, Dickinson and Company (NYSE: BDX) (medical technology and manufacturing) from 2017 until 2021. Prior to that, he was senior vice president of Science, Technology and Clinical Affairs for C.R. Bard, Inc. (medical technology manufacturing), which was acquired by BDX in 2017, managing director of Early Stage Partners, a venture capital fund, and president and chief executive officer of Cook Incorporated, a privately held medical device manufacturer. Dr. DeFord brings a wealth of diverse experiences resulting from serving in various leadership positions over the past 35 years, he holds 14 U.S. patents, is the author of numerous peer-reviewed scientific papers, and has a Ph.D in Electrical Engineering. His experience also includes leading and overseeing mergers and acquisitions and corporate governance initiatives. Dr. DeFord s expertise in the medical device sector and executive experience in multi-billion dollar, global companies enable him to make significant contributions to discussions regarding the Company s strategy and growth.